| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |